4
Changes in Ownership
NRX Pharmaceuticals, Inc. Filed Acc 0001415889-22-012652
CHIEF FINANCIAL OFFICER bought 30,000 shares at $1.10 ($33,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| VAN VOORHEES SETH CHIEF FINANCIAL OFFICER | 2022-12-16 | Purchase | +30,000 | $1.10 | $33,000 | 46,337 | D |
| Open-market purchases · 30,000 sh · avg $1.10 · $33,000 | |||||||
Loading xslF345X03/form4-12192022_121236.xml…